Using TBK1 Inhibitors to Stop Cancer in Its Tracks
Tuesday, 29 October 2019
TBK1 Inhibitors, Autoimmune Disorders, and Cancer – Inflammation is a crucial step within the immune response, helping our bodies eliminate disease. However, it can also be a burden where misregulation creates a variety of maladies including cancer. As inflammation persists, becoming chronic, the beneficial elements can be lost and disease occurs. It’s not just autoimmune
- Published in Emerging Targets
No Comments